Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration. 2003

A Lanzini, and M G De Tavonatti, and B Panarotto, and S Scalia, and A Mora, and F Benini, and O Baisini, and F Lanzarotto
Nuclear Medicine, Spedali Civili and University of Brescia, Italy. lanzini@med.unibs.it

BACKGROUND Whether ileal absorption of bile acid is up or downregulated in chronic cholestasis is still debated, and most evidence has come from animal studies. OBJECTIVE To compare ileal bile acid absorption in patients with primary biliary cirrhosis (PBC) and in healthy control subjects, and to assess the effect of ursodeoxycholic acid (UDCA). METHODS We studied 14 PBC patients before and during (n=11) UDCA administration, 14 healthy control subjects, and 14 Crohn's disease patients (as disease controls). METHODS We used cholescintigraphy to measure retention in the enterohepatic circulation over five successive days of the bile acid analogue (75)Se-homocholic acid-taurine ((75)SeHCAT) as an index of ileal bile acid absorption. Results were expressed as (75)SeHCAT fractional turnover rate (FTR) and t(1/2)12. RESULTS (75)SeHCAT FTR was 0.19 (0.11)/day, 0.34 (0.11)/day (p<0.001), and 0.83 (0.32)/day in PBC patients, healthy controls (p<0.0001), and Crohn's patients (p<0.001), respectively, which increased to 0.36 (0.16)/day in PBC patients during UDCA treatment (p<0.005). (75)SeHCAT t(1/2)12 was 4.8 (2.1) days in PBC patients, 2.2 (0.5) days (p<0.001) in healthy controls, and 1.0 (0.5) days (p<0.001) in Crohn's disease patients. (75)SeHCAT t(1/2)12 decreased to 2.2 (0.93) days (p< 0.001) in PBC patients during UDCA treatment. CONCLUSIONS Our results support the concept that ileal bile acid absorption is upregulated in PBC patients, and that this effect may contribute towards damaging the cholestatic liver. This upregulation of bile acid absorption is abolished by UDCA.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008105 Liver Cirrhosis, Biliary FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes. Biliary Cirrhosis,Biliary Cirrhosis, Primary,Biliary Cirrhosis, Secondary,Cholangitis, Chronic Nonsuppurative Destructive,Liver Cirrhosis, Obstructive,Primary Biliary Cholangitis,Biliary Cirrhosis, Primary, 1,Primary Biliary Cirrhosis,Secondary Biliary Cholangitis,Secondary Biliary Cirrhosis,Biliary Cholangitides, Primary,Biliary Cholangitis, Primary,Biliary Cholangitis, Secondary,Cholangitides, Primary Biliary,Cholangitis, Primary Biliary,Cholangitis, Secondary Biliary,Cirrhosis, Biliary,Cirrhosis, Secondary Biliary,Liver Cirrhoses, Biliary,Obstructive Liver Cirrhosis,Primary Biliary Cholangitides,Secondary Biliary Cholangitides
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002756 Cholagogues and Choleretics Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). Choleretics,Cholagogues,Cholagogues, Choleretics,Choleretics and Cholagogues,Hydrocholeretics
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile

Related Publications

A Lanzini, and M G De Tavonatti, and B Panarotto, and S Scalia, and A Mora, and F Benini, and O Baisini, and F Lanzarotto
January 1985, European journal of nuclear medicine,
A Lanzini, and M G De Tavonatti, and B Panarotto, and S Scalia, and A Mora, and F Benini, and O Baisini, and F Lanzarotto
January 1982, European journal of nuclear medicine,
A Lanzini, and M G De Tavonatti, and B Panarotto, and S Scalia, and A Mora, and F Benini, and O Baisini, and F Lanzarotto
January 2019, Revista espanola de medicina nuclear e imagen molecular,
A Lanzini, and M G De Tavonatti, and B Panarotto, and S Scalia, and A Mora, and F Benini, and O Baisini, and F Lanzarotto
June 1999, Hepatology (Baltimore, Md.),
A Lanzini, and M G De Tavonatti, and B Panarotto, and S Scalia, and A Mora, and F Benini, and O Baisini, and F Lanzarotto
August 2002, European journal of clinical investigation,
A Lanzini, and M G De Tavonatti, and B Panarotto, and S Scalia, and A Mora, and F Benini, and O Baisini, and F Lanzarotto
September 2014, Medwave,
A Lanzini, and M G De Tavonatti, and B Panarotto, and S Scalia, and A Mora, and F Benini, and O Baisini, and F Lanzarotto
August 2002, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA,
A Lanzini, and M G De Tavonatti, and B Panarotto, and S Scalia, and A Mora, and F Benini, and O Baisini, and F Lanzarotto
May 1993, Digestive diseases and sciences,
A Lanzini, and M G De Tavonatti, and B Panarotto, and S Scalia, and A Mora, and F Benini, and O Baisini, and F Lanzarotto
December 1991, Hepatology (Baltimore, Md.),
A Lanzini, and M G De Tavonatti, and B Panarotto, and S Scalia, and A Mora, and F Benini, and O Baisini, and F Lanzarotto
August 1989, Gut,
Copied contents to your clipboard!